reason report
partnership may expand near-term impact like
bottom line yesterday wall street journal cite sourc
report walgreen boot allianc mp
inc op may talk take stake
detail regard discuss scarc sourc claim
compani engag wide-rang talk includ
possibl expand exist partnership remind
june walgreen announc pilot program
kansa citi two compani team offer senior-
focus primari care servic insid two walgreen store given
news wall street journal would appear clinic
perform well walgreen consid take
equiti stake sinc initi locat limit
two store suspect two compani talk
expand number locat offer senior partner
primari care servic time view discuss
overli materi walgreen oper retail store
even partnership expand store
believ increment volum revenu impact would overli
signific also believ interest outright
acquir health-plan maintain mp pt
initi agre open two primari
locat insid store kansa citi metro area
locat expect featur in-stor health navig
servic senior offer repres rang
educ identifi local support group find senior fit
class store meant develop long-term relationship
medicar member allow senior access rang servic
includ diabet educ creat holist approach health
report talk indic compani look build
exist senior-focus neighborhood approach health togeth
compani bring togeth primari care pharmaci in-person health
plan support servic medicar beneficiari potenti
expans collabor among two compani build prior
commit help senior live healthier live
build clinic interest in-lin
overal strategi seem want partner mani
plan pbm possibl order remain somewhat agnost
channel attract volum store believ
want acquir plan major pbm time suspect
want remain good term mani plan possibl
believ strategi typic allow other channel
continu expert seek partner
order drive valu
net debt total capit
price-to-earnings lt ep growth
ep
year price history/av daili volume mil
creat bluematrix
compani inform leerink partner llc research
ep exclud acquisition-rel cost acquisition-rel amort non-recur item includ lifo adjust revenu billion
pleas refer page import disclosur price chart analyst certif
view news indic compani
experienc better expect result compani
announc initi partnership june two locat
expect open fall encourag hear
compani engag discuss potenti expand
partnership month two pilot
anticip consider financi implic near term
see longer term valu expand partnership walgreen
potenti benefit increas foot traffic store result
rx front-end volum two locat
initi trial expect expans partnership
immedi measur effect walgreen perform
near-term long-term howev encourag see
walgreen remain focus improv clinic presenc within
retail locat believ typic want work other
channel drive market share gain oppos build solut
exampl partnership labcorp
instead creat lab test deliv test
store walgreen would rather work establish vendor
believ want acquir build health-plan time
largest global pharmaci led retail pharmaceut wholesal
organ world walgreen us drugstor chain largest pharmaci chain
us store count industri size improv purchas power brand-nam
recognit improv store traffic overal volum health plan self-insur
employ seek reduc medic cost via restrict network believ walgreen in-stor
clinic may provid attract altern plan walgreen nation presenc
also attract mani plan view provid larg corpor broad access
view gener launch wave next sever year posit impact
bottom line walgreen balanc reward custom loyalti program help lower
print ad cost bring individu market benefit recent work increas wba
privat brand product share mix well new front-end merchandis strategi
posit impact same-stor sale profit addit walgreen recent deal
allianc boot offer promis long-term synergi global
growth back lost share esrx network disput
although grow accept narrow network remain risk walgreen provid
health plan wide array servic includ infus specialti dispens lab servic
hospit partnership primari care servic case walgreen also earli
mover advantag purchas jv boot deal walgreen
pbm may advantag case make retail chain payer agnost
mani strength believ retail channel face signific challeng
includ increasingli competit environ seek creat
restrict prefer narrow network deal effort captur store traffic volum
medacorp specialist check indic retail rate reduc
case keep pressur retail gross margin
furthermor on-going gener launch believ wave
larg behind us becom increasingli difficult show gross margin expans
retail also believ transact posit busi stock howev
deterior lose share even though deal approv investor
sentiment stock name appear low lastli threat amazon entri
pharmaci servic space continu weigh stock believ
retail exposur sinc own pbm given risk
concern rate share market perform
next month expect share trade ep
would put stock price multipl reflect on-going reimburs
pressur minim accret slowdown volum growth headwind
intern busi believ posit win share
becom extens network vast array clinic capabl believ new
manag team take step reduc overal cost increas sale higher margin
front-stor product posit retail rate remain signific pressur
brand gener price also headwind becom aggress
overal respons market also overhang unlik abat time soon
given challeng concern rate share market perform
competit high retail pharmaci industri highli competit contract
pbm manufactur also competit walgreen compet chain
independ drug store well mail order prescript provid groceri store on-line
pharmaci pharmaceut vendor chang competit landscap
impact rx volum neg impact compani sale earn
macroeconom regulatori climat uncertainti continu econom slowdown
 would bode poorli sinc above-averag unemploy rate drive lower
level consum spend would decreas prescript drug util regulatori
environ also fair amount uncertainti time impact variou
healthcar reform provis could materi impact wba oper nation emphasi
reduc healthcar cost could also spawn reimburs pressur new way contain
healthcar cost devis implement
intern exposur execut risk walgreen merger allianc boot increas
exposur intern market increas currenc exposur regulatori risk
wba partnership uniqu approach contract distribut
compani fail execut vision accret could expect
season time cost adjust swing result front-end sale
prescript sale compon season sale also lumpi depend
holiday line calendar sever cold cough flu season
magnitud compani lifo provis also fluctuat given quarter depend
inventori level sale inflat also swing result contribut earn
miss beat
amazon entri amazon may seek disrupt pharmaci market enter
retail market buy build contract pbm news topic pose
headlin risk share amazon could formid competitor mail cash pay
incom statement model fiscal year end august mm
sale
revenu
revenu
gross profit sg spread bp
equiti earn ab
share allianc boot associ
sale acquisit adjust
revenu
revenu
net earn attr nci
revenu
total non-gaap adjust tax
compani report leerink partner llc estim
revenu
revenu
equiti earn allianc boot
sale acquisit adjust
compani report leerink partner llc estim
incom statement model fiscal year end august mm
revenu
revenu
revenu
revenu
adjust equiti earn
elimin unalloc
sale
compani report leerink partner llc estim
incom statement model fiscal year end august mm
sale
equiti earn allianc boot
share allianc boot associ
previous held equiti interest
tax earn equiti method invest
net incom attrib non-control interest
net incom attrib walgreen
gain previous held equiti interest
increas decreas fair market valu warrant
partial releas capit loss valuat allow
loss sale busi
gain previous held equiti interest
increas decreas fair market valu warrant
partial releas capit loss valuat allow
compani report leerink partner llc estim
